Stockreport

Zevra Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

Zevra Therapeutics, Inc.  (ZVRA) 
PDF Zevra Therapeutics Q4 net revenue of $34.1 million, representing 31% growth quarter-over-quarter FY net revenue of $106.5 million driven by growth in MIPLYFFA ® net [Read more]